Fempro 2.5 mg Tablet
  1. Home
  2. Pharma Products
  3. Cipla Ltd
  4. Fempro 2.5 mg Tablet

Fempro 2.5 mg Tablet

Fempro 2.5 mg Tablet contains letrozole 2.5 mg, an aromatase inhibitor used mainly for hormone-sensitive breast cancer. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Letrozole lowers estrogen production, which can help slow the growth of estrogen-dependent cancer cells.

BUY NOW

Category

Fempro 2.5 mg Tablet is primarily used for hormone receptor-positive breast cancer in postmenopausal women. Letrozole inhibits the aromatase enzyme, reducing estrogen production in the body and limiting hormonal stimulation of certain breast cancer cells. The dosage and treatment duration are determined by the treating oncologist according to the patient’s condition and treatment response. Regular medical follow-up may be required during long-term treatment.

Technical Specification

Specification Details
Active Ingredient Letrozole
Strength 2.5 mg
Dosage Form Film-Coated Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer/Marketer Cipla Ltd.

Product Also Known As

Fempro 2.5 mg Tablet, Fempro 2.5 Tablet, Fempro Letrozole Tablet, Letrozole 2.5 mg Tablet, Letrozole Breast Cancer Tablet, Letrozole Aromatase Inhibitor Tablet